SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Oxford GlycoSciences Plc
An SI Board Since January 2000
Posts SubjectMarks Bans
469 13 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
269<i>Did this "delgijer" create this, or is this a cut and paste fnigel bates-12/16/2002
268Wo! Where did this come from? Did this "delgijer" create this, or isscaram(o)uche-12/16/2002
267Thanks. The more we know about these suckers, the better. It's obvious thascaram(o)uche-12/15/2002
266Thanks. For some reason, my first search in PubMed with N-butyldeoxygalactonojituck-12/15/2002
265here's a tad of insight re. the second generation candidate in phase I testiscaram(o)uche-12/15/2002
264J Lipid Res 2002 Nov;43(11):1837-45 Glucosylceramide modulates membrane trafficscaram(o)uche-12/15/2002
263>> Anyone seen data on OGT - 923? I saw a vague reference to a better sidescaram(o)uche-12/15/2002
262Here we go: 100mg, three times daily. Here's the leaflet from EMEA website tuck-12/15/2002
261Here's that NB-DNJ abstract: >>Published online before print Decembertuck-12/15/2002
260no, no, no, no. wasn't talking about contraception. but they do have a secscaram(o)uche-12/9/2002
259Just joining the gaffaws about the second indication. Agree about the the serikeokalani'nui-12/9/2002
258Do you really think the FDA would go for this indication given the side effects?tuck-12/9/2002
257The disease is worse than the cure. Bottom line.scaram(o)uche-12/9/2002
256and those GI side effects...keokalani'nui-12/9/2002
255Can't find the abstract. If it wasn't for the possible side effects, I&tuck-12/9/2002
254Reuters Drug may act as male contraceptive - study Monday December 9, 6:54 pm ETscaram(o)uche-12/9/2002
253more deep stuff from Progen...... International Oncology Experts Meet in Brisbascaram(o)uche-11/27/2002
252listening to replay of webcast now..... first Q in Q&A addressed pricing. scaram(o)uche-11/26/2002
251Worldwide licence agreement signed by OGS and Actelion; Extension of European Pascaram(o)uche-11/26/2002
250European Commission Approval for Zavesca(TM) European Launch of Type 1 Gaucher Tscaram(o)uche-11/26/2002
249Encouraging Human Trial Data Presented at International Cancer Conference for Prscaram(o)uche-11/25/2002
248OXFORD, England, Nov. 21 /PRNewswire-FirstCall/ -- Oxford GlycoSciences Plc (Nasnigel bates-11/21/2002
247just parking........ (wasn't there an IMGN subsidiary that was working on Cscaram(o)uche-11/19/2002
246Headline might have read: "OGS can not find US acquisition candidate willikeokalani'nui-11/13/2002
245OGS turns back on US.... <i>By Ben Hirschler, European Pharmaceuticals Conigel bates-11/13/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News